title: Anti-nociceptive effect induced by somatostatin released from sensory nerve terminals and by synthetic somatostatin analogues in the rat.
abstract: In rats anaesthetized with urethan and pretreated with pipecuronium bromide nocifensive reaction of blood pressure elevation evoked by intraarterial capsaicin injection was inhibited over 40 min by bilateral antidromic stimulation of the sensory fibres of the sciatic nerves. Rise in blood pressure, heart rate and respiratory frequency evoked by capsaicin were markedly diminished after smearing 1% mustard oil on the acutely denervated hindpaws indicating a release of mediators with anti-nociceptive action from cutaneous nociceptors. Intravenous injection of the putative mediator somatostatin (10 microg/kg) or its analogues RC-160 and TT-232, but not octreotide inhibited the cardiorespiratory and blood pressure responses evoked by topical cutaneous application of mustard oil or capsaicin instillation into the eye. It is concluded, that the endocrine and the anti-nociceptive effects of somatostatin are mediated through distinct receptor subtypes and therefore, TT-232, a novel heptapeptide analogue without endocrine action, is a promising analgesic compound.
authors.affiliation: Department of Pharmacology and Pharmacotherapy, Neuropharmacological Research Group of the Hungarian Academy of Sciences, University Medical School of Pécs.
authors.forename: Z
authors.initials: Z
authors.lastname: Helyes
authors.forename: M
authors.initials: M
authors.lastname: Thán
authors.forename: G
authors.initials: G
authors.lastname: Oroszi
authors.forename: E
authors.initials: E
authors.lastname: Pintér
authors.forename: J
authors.initials: J
authors.lastname: Németh
authors.forename: G
authors.initials: G
authors.lastname: Kéri
authors.forename: J
authors.initials: J
authors.lastname: Szolcsányi
mesh_terms: D000700:Analgesics / Q000494:pharmacology*; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects; D002211:Capsaicin / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D009149:Mustard Plant; D009411:Nerve Endings / Q000378:metabolism*; D009475:Neurons, Afferent / Q000378:metabolism* / Q000502:physiology; D009619:Nociceptors / Q000502:physiology*; D010456:Peptides, Cyclic / Q000494:pharmacology*; D010936:Plant Extracts / Q000008:administration & dosage / Q000494:pharmacology; D010938:Plant Oils; D051381:Rats; D017208:Rats, Wistar; D012119:Respiration / Q000187:drug effects; D012867:Skin / Q000294:innervation; D013004:Somatostatin / Q000031:analogs & derivatives* / Q000378:metabolism / Q000494:pharmacology / Q000502:physiology*
chemical_list: D000700:Analgesics; D010456:Peptides, Cyclic; D010936:Plant Extracts; D010938:Plant Oils; C051458:vapreotide; C094462:TT2-32; D013004:Somatostatin; D002211:Capsaicin; C027793:mustard oil